Pilot randomised controlled trial of a novel form of exercise on parkinsonism symptoms.

ABSTRACT:

Objective

Exercise-assistance strategies are useful in allowing mobility-impaired patients to access the benefits of exercise. This trial is the first of the Reviver device, which facilitates exercise via a novel strength and balance training mechanism. The objective was to examine the effect of a 12-week Reviver intervention on symptoms of Parkinsonism, and to pilot the randomised controlled trial design, including randomisation and acceptance of the exercise intervention.

Methods

This was a pilot, parallel-arm randomised controlled trial with assessor blinding. Participants (n=30: 22 with Parkinson's disease (PD) and 8 with atypical Parkinsonism conditions (AP)) were allocated to either experimental or control group. The experimental group received 24 session

SUBMITTER: Sinclair B 

PROVIDER: S-EPMC12778312 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature